Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease

Conclusions:
In patients with diabetes and kidney disease, ACEis and ARBs are consistently protective for the development of ESRD. Use of ACEis alone additionally reduces deaths and increases the risk for cough. Use of ARBs alone increases the risk for hyperkalemia without additional benefit of death protection.

Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - July 2, 2016 Category: Biomedical Science Authors: Shen, J., Huang, Y.-M., Song, X.-N., Hong, X.-Z., Wang, M., Ling, W., Zhang, X.-X., Zhao, H.-L. Tags: Original Article Source Type: research